The Southern African Journal of Infectious Diseases (SAJID), formerly called the Southern African Journal of Epidemiology and Infection (SAJEI), first appeared in 1985 as a joint publication of the Infectious Diseases Society of Southern Africa (IDSSA), the Sexually Transmitted Diseases Society of Southern Africa (STDSSA) and the Epidemiology Society of Southern Africa, the latter having subsequently been succeeded by the Public Health Association of South Africa (PHASA). Presently SAJID is published under the auspices of the Federation of Infectious Diseases Societies of South Africa which is an umbrella organisation incorporating IDSSA, STDSSA as well as the Infection Control Society of South Africa (ICASA), the National Antibiotic Study Forum (NASF) of South Africa, and the South African Society of Travel Medicine (SASTM).

Publications of SAJID centre round aspects of epidemiology and infection, particularly those of importance to the societies of FIDSSA. Topics around infection include clinical and epidemiological aspects of communicable diseases, laboratory diagnosis of infections, characterisation of infective agents by molecular techniques and the study of transmission patterns of pathogens in institutional and community settings. Other infection related studies cover surveillance of vaccine-controllable and other infectious diseases, drug susceptibility patterns of hospital-acquired and community-acquired pathogens and infection control strategies for the southern Africa region. SAJID also promotes greater collaboration between clinically oriented and laboratory-based divisions within the FIDSSA societies, and the establishment of quality assurance programmes and other measures to enhance and maintain standards of diagnostic and public health microbiology.

Scientific papers in the SAJID aim to advance the understanding of all aspects of epidemiology, public health, clinical microbiology and infection. The journal strives to promote research and exchange of information on specific areas of infectious diseases, medical microbiology and virology, covering fields of interest of the societies of FIDSSA and PHASA. Manuscripts describing research performed at southern African institutions and in southern African settings enjoy a high priority, as do health matters covering Africa and the developing world, as well as global issues such as malaria and other tropical diseases, tuberculosis, sexually transmitted infections and HIV/AIDS. The scope of interest of SAJID is wide but the journal aims to maintain and improve the standard of its publications.

New review of clinical studies shows that antidepressants are effective, but must be given a chance to work

New review of clinical studies shows that antidepressants are effective, but must be given a chance to work Depression affects millions of people worldwide.1 ref 1A It can be severely disabling, impacting general health and wellbeing, and performance at work and...

The Science is in the Sample – provided it is Representative

Current sampling practice is a result of the combination of statistics with scientific knowledge about the product/material being sampled.  Such knowledge is acquired through experimentation and the use of various sampling techniques until reproducible results, from representative samples, can be obtained. 

NEW LEADERSHIP AT THE HELM OF GENERICS AND BIOSIMILAR MEDICINES ASSOCIATION

Generic and Biosimilar Medicines of Southern Africa (GBMSA), formerly known as the National Association of Pharmaceutical Manufacturers (NAPM), has appointed Erik Roos, CEO of Pharma Dynamics as Vice Chairperson to support the existing Chairperson, Lorraine Keyser, CEO of Dr Reddy’s, as of June 2018.

One year on – Novartis, DST and SAMRC MoU builds scientific capability in South Africa

One year after the signing of a Memorandum of Understanding (MoU) between Novartis, the South African Department of Science and Technology (DST) and South African Medical Research Council (SAMRC), Novartis reports that the collaboration is revealing significant latent potential for scientific discovery in South Africa.

The SpineCor Scoliosis Brace – A first of its kind in South Africa

MER Healthcare Consulting has introduced the new Scoliosis SpineCor Brace to the South African market. SpineCor is 3 dimensional dynamic brace used to help prevent progression of a curve in Idiopathic Scoliosis for adolescents and degenerative painful scoliosis in adults.